InsidersTradesSigma
Follow the 삼성제약 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 삼성제약 has recorded 1 insider filings. Market capitalisation: €129.5bn. The latest transaction was filed on 11 March 2026 (Other). Among the most active insiders: 삼성제약. Every trade is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.